CAT
55
-2
CINF
58
3
HP
36
2
ADT
55
5
URBN
54
4
L
67
3
EBAY
56
3
WDC
66
-2
LRCX
56
-5
VTR
63
6
LB
55
7
REGN
53
-3
SPG
30
3
SHW
43
-3
WM
80
6
APA
69
2
KHC
42
8
AAP
26
-7
SWK
46
-3
PG
20
-2
CAT
55
-2
CINF
58
3
HP
36
2
ADT
55
5
URBN
54
4
L
67
3
EBAY
56
3
WDC
66
-2
LRCX
56
-5
VTR
63
6
LB
55
7
REGN
53
-3
SPG
30
3
SHW
43
-3
WM
80
6
APA
69
2
KHC
42
8
AAP
26
-7
SWK
46
-3
PG
20
-2
Financhill
Back

Xvivo Perfusion AB Vs. Apogee Therapeutics, Inc. Industry Stock Comparison

Sell
36

XVIPF
Xvivo Perfusion AB

Last Price:
$22.81
Seasonality Move:
-4.28%
Sell
44

APGE
Apogee Therapeutics, Inc.

Last Price:
$84.40
Seasonality Move:
-11.77%
Sell
36
Xvivo Perfusion AB (XVIPF) is a Sell

Is Xvivo Perfusion AB a Buy, Sell or Hold?

  • The current Xvivo Perfusion AB [XVIPF] share price is $22.81. The Score for XVIPF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • XVIPF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Apogee Therapeutics, Inc. (APGE) is a Sell

Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XVIPF Stock Price Chart

What is Xvivo Perfusion AB's stock price today?

  • The Xvivo Perfusion AB share price today is $22.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XVIPF is experiencing slight buying pressure.

APGE Stock Price Chart

What is Apogee Therapeutics, Inc.'s stock price today?

  • The Apogee Therapeutics, Inc. share price today is $84.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

XVIPF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.84 Buy
Relative Strength Index (14 RSI): 78.85 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.53 - 21.15) Buy
Bollinger Bands (100): (18.31 - 22.67) Buy

APGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: 432550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 79.44) Buy
Bollinger Bands (100): (66.23 - 78.47) Buy

XVIPF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.98 Buy
20-day SMA: 19.97 Buy
50-day SMA: 21.55 Buy
200-day SMA: 21.27 Buy
8-day EMA: 20.53 Buy
20-day EMA: 14.6 Buy
50-day EMA: 7.84 Buy
200-day EMA: 2.31 Buy

APGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.91 Buy
20-day SMA: 75.21 Buy
50-day SMA: 71.36 Buy
200-day SMA: 57.28 Buy
8-day EMA: 80.37 Buy
20-day EMA: 76.41 Buy
50-day EMA: 73.33 Buy
200-day EMA: 61.58 Buy

Xvivo Perfusion AB Earnings Growth & XVIPF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.

Xvivo Perfusion AB Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):